AzTrials
AzTrials

Tracheostomy ComplicationPETRISNCT05792098

Percutaneous Dilatational Tracheostomy and Thyroid Isthmus Penetration

A study testing percutaneous dilatational tracheostomy (PDTS), Ultrasound examination and Bronchoscopy in people with Tracheostomy Complication, run by Charles University, Czech Republic at 1 site in Czechia.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

A prospective randomized interventional study will be conducted in the Military University Hospital Prague at the department of Anesthesiology and Intensive care. The incidence of thyroid isthmus penetration will be evaluated during percutaneous dilatational tracheostomy in two groups (ultrasound-guided puncture vs. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Tracheostomy Complication
What is being tested?
percutaneous dilatational tracheostomy (PDTS), Ultrasound examination and Bronchoscopy
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
200 participants
Where
1 siteCzechia
Study dates
6 Apr 2023to 12 Dec 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • 18 Years and older
  • long-term need for mechanical ventilation

Who cannot join

  • not willing to participate

Trial locations and contacts

1 site in 1 country.

Czechia1 site
  • Military University Hospital Prague

    Prague, 16902

Other trials in Czechia

About this study

A prospective randomized interventional study will be conducted in the Military University Hospital Prague at the department of Anesthesiology and Intensive care. The incidence of thyroid isthmus penetration will be evaluated during percutaneous dilatational tracheostomy in two groups (ultrasound-guided puncture vs. standard approach using only anatomical landmarks).

Read the detailed description

A prospective randomized interventional study will be conducted in the Military University Hospital Prague at the department of Anesthesiology and Intensive care. Patients indicated by the attending physician to percutaneous dilatational tracheostomy (PDTS) due to long-term need for mechanical ventilation will be randomly divided into two groups. The standard procedure group will undergo PDTS by the attending physician in the standard manner based on clinical examination and anatomical landmarks using bronchoscopic navigation. In the second group, the attending physician will additionally use ultrasound navigation during the procedure. After insertion of the guidewire, before dilation is performed, patients in both groups will be examined by ultrasound by an independent physician - the study investigator - who will verify the position of the guidewire and its relationship to the surrounding structures. In case of malposition of the guidewire (unacceptable lateral or craniocaudal), the penetration site will be adjusted and the PDTS completed.

Being tested
percutaneous dilatational tracheostomy (PDTS), Ultrasound examination, Bronchoscopy
Keywords
percutaneous dilatational tracheostomy, ultrasound, mechanical ventilation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • percutaneous dilatational tracheostomy (PDTS)Procedure or surgery

    Tracheostomy made by percutaneous dilatational technique

  • Ultrasound examinationDiagnostic test

    Ultrasound verification of guidewire position

  • BronchoscopyDiagnostic test

    Bronchoscopic control of guidewire position

Study groups in NCT05792098
Study groupRoleWhat they receive
Standard procedure groupActive comparatorThe standard procedure group will undergo PDTS by the attending physician in the standard manner based on clinical examination and anatomical landmarks using bronchoscopic control.
Receives: Procedure: percutaneous dilatational tracheostomy (PDTS); Diagnostic Test: Bronchoscopy
Ultrasound navigated groupActive comparatorUltrasound navigated group, the attending physician will additionally use ultrasound navigation during the procedure.
Receives: Procedure: percutaneous dilatational tracheostomy (PDTS); Diagnostic Test: Ultrasound examination; Diagnostic Test: Bronchoscopy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The guidewire penetration through the thyroid isthmus.

    Incidence of guidewire penetration through the thyroid isthmus in standard and ultrasound navigated percutaneous dilatational tracheostomy.

    Measured: During procedure

  2. Monitoring the incidence of early postoperative complications.

    The incidence of bleeding from tracheostomy canal during hospitalization depending on guidewire position, defined as the need for any intervention to stop the bleeding.

    The incidence of tracheostomy canal infection during hospitalization depending on guidewire position, defined as the presence of any clinical signs of inflammation (swelling, redness, pain, secretion production, dehiscence).

    Measured: Up to 10 days

Secondary outcomes (1)
  1. Using ultrasound examination as a tool for PDTS navigation in terms of correct puncture site.

    Monitoring the frequency of guidewire position changes based on ultrasound examination.

    Measured: During procedure

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Mar 2023
  2. Study start6 Apr 2023
  3. Primary completion1 Apr 2025 (estimated)
  4. Study completion12 Dec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
200 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05792098
Sponsor's protocol ID
PETRIS_01
Acronym
PETRIS
Status last verified
Mar 2023
First submitted
7 Mar 2023
Last updated
11 Apr 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Gobatto ALN, Besen BAMP, Tierno PFGMM, Mendes PV, Cadamuro F, Joelsons D, Melro L, Carmona MJC, Santori G, Pelosi P, Park M, Malbouisson LMS. Ultrasound-guided percutaneous dilational tracheostomy versus bronchoscopy-guided percutaneous dilational tracheostomy in critically ill patients (TRACHUS): a randomized noninferiority controlled trial. Intensive Care Med. 2016 Mar;42(3):342-351. doi: 10.1007/s00134-016-4218-6. Epub 2016 Feb 1.

    PubMed 26831676
  • Plata P, Gaszynski T. Ultrasound-guided percutaneous tracheostomy. Anaesthesiol Intensive Ther. 2019;51(2):126-132. doi: 10.5114/ait.2019.86277.

    PubMed 31268274
  • Rara A, Sotak M, Hynek M, Kovacic K, Filipovsky T, Tyll T. Percutaneous dilatational tracheostomy and thyroid isthmus penetration (PETRIS). Anaesth Crit Care Pain Med. 2026 May 30;45(6):101863. doi: 10.1016/j.accpm.2026.101863. Online ahead of print.

    PubMed 42217576

Questions about this trial

What is this clinical trial studying?

A study testing percutaneous dilatational tracheostomy (PDTS), Ultrasound examination and Bronchoscopy in people with Tracheostomy Complication, run by Charles University, Czech Republic at 1 site in Czechia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 11 Apr 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Czechia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The guidewire penetration through the thyroid isthmus. (time frame: During procedure). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05792098, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Apr 2023; AzTrials last refreshed its copy on 6 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in